However, we found no evidence of CpG hypermethylation in the COX-2 promoter or other gene regions tested, suggesting a different mechanism for COX-2 silencing in lung fibrosis to that observed in cancer [33,34]. The gene discussed is PTGS2; the disease is cancer.